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Ruud HJ Verstegen1,2, Roeland WNM van Hout3 and Esther de Vries1*Abstract
Background: Children with Down syndrome suffer from recurrent respiratory tract and ear-nose-throat complaints that
influence daily life. Little is known about the frequency of these complaints, as well as their relation to co-morbidity
and ageing.
Methods/design: A prospective web-based parent-reported observational study was designed for parents having a
child with Down syndrome (age 0 to 18 years). Upon registration, parents receive an email containing a link to a weekly
questionnaire regarding respiratory symptoms during two consecutive years. Additionally, at the beginning, after one
year and at the end of the study they receive an extended questionnaire concerning baseline data, daily activities and
medical history. The data will be compared to the ongoing “child-is-ill” study, which collects weekly data in an identical
fashion in children that are considered to be “normal as to being ill” by their parents.
Discussion: This study will provide important data on the epidemiology of respiratory symptoms in children with
Down syndrome, which will be useful for further studies on treatment options. Also, this study will gain insight in
healthcare usage and work absence due to the child’s illnesses.
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Down syndrome (DS) is the most common genetic
cause of developmental delay in humans, affecting
approximately 1 in 700 liveborn infants in the Netherlands
[1,2]. Numerous health issues are related to DS. In
newborns, hypotonia, facial characteristics and congenital
heart disease (CHD) are variably present. Later in life, DS
is associated with an increased incidence of hematological
malignancies and auto-immune diseases, such as celiac
disease, hypothyroidism and type 1 diabetes mellitus [3].
Respiratory complications and ear, nose and throat (ENT)
diseases are a major contributor to morbidity and mortality
in patients with DS. Up to 80% of all hospitalizations and
admissions to a pediatric intensive care unit of children
with DS is caused by lower respiratory tract infections [4,5].
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reproduction in any medium, provided the orwith DS [6-11]. Moreover, up to 29% of deaths in DS are
related to pneumonia, influenza and aspiration, with
increased standardized mortality odds ratio of 3.00-4.15 in
children with DS aged <20 years [12,13]. In addition, we
recently showed that parent-reported recurrent respiratory
tract infections in 8-year-old children with DS are
associated with more impaired mental and motor
development, lower health related quality of life and more
behavioral problems compared to children whose parents
report no increased respiratory tract infections in their
child [14].
In a retrospective Finnish chart study, up to 40% of
children and young adults (aged <30 years) with DS have
had at least one pneumonia, partly caused by aspiration
[15]. Schieve et al. report that 27.6% of children with DS
compared to 17.5% of children without DS or other
cause of mental retardation had symptoms of head/chest
cold in the 2 weeks prior to the conduction of the survey
[9]. Another study showed that 17.6% of school-aged
children with DS have a continual runny nose and that 12%
have had more than 3 upper respiratory tract infections inral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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found in children with DS and include ear infections,
hearing impairment and obstructive sleep apnea syndrome,
[17-21] which can subsequently lead to behavioral problems
and more developmental delay [22,23].
Treatment, and especially prevention of recurrent
respiratory tract infections is challenging. Anatomical
and physiological changes in the respiratory and ENT
tract in children with DS are inherent to the syndrome
and leave little room for improvement, except adenotomy
and/or tonsillectomy. The use of prophylactic antibiotics
to decrease the frequency of respiratory infections has
never been studied in children with DS (nor in healthy
children). Also, although palivizumab is sometimes
prescribed in children with DS to prevent severe RSV
disease, there have been no studies to evaluate the effect of
this treatment. At last, other – more active – diagnostics
and treatment by ENT specialists may be beneficial since
adenotomy and/or tonsillectomy do not help all children
[24]. In order to evaluate treatment options there is a
need for more data on the exact incidence of respiratory
symptoms and their evolvement in time to define patient
groups who may benefit from these therapies. In this paper
we describe the construction of a web-based observational
study of respiratory tract infections in children with DS.
Aim of the study
The primary goal of this study is to describe the frequency
of respiratory symptoms in relation to age and comorbidity,
with special focus on development of symptoms in time.
The secondary goal is to show the medical and social
consequences of respiratory symptoms such as doctor
visits, absence from school and care leave of parents.
Thirdly, we will relate the presence of co-morbidities in
children with DS and their development in time with
the obtained data.
Methods/Design
We designed a prospective web-based parent-reported
observational study for which inclusion started in March
2012. Approval of the study protocol was obtained from
the Medical Ethical Review Board “METOPP”, Tilburg,
the Netherlands.
Inclusion of participants
Parents or legal guardians of a child with DS in the
Netherlands aged 0-18 years are eligible for inclusion in
this study. By estimation, the total age cohort consists
of approximately 4500 children. Specialized pediatric
outpatient clinics for DS were contacted and received
posters for their waiting room. Also, the Dutch Down
Syndrome Foundation and related organizations made the
study more widely known by publishing a call on their
websites. Finally, social media were used to increaseawareness of this study. Parents who are interested
can obtain more information about and register for
this study though the study website. According to
Statistics Netherlands, almost all families with children in
the Netherlands have access to the Internet and would
therefore be eligible to participate [25]. However, parents
should be able to understand Dutch in order to be capable
to register for this study.
Data collection
All data for this study will be collected through web-based
questionnaires. Participants receive email invitations, which
are sent by an automatic data managing system (Research
Manager, Nova Business Software, the Netherlands). At
baseline, the parents are asked to complete a questionnaire,
which includes questions on the composition of the
household of the child, daily activities of their child
(i.e. child care attendance or visiting primary or secondary
school) and medical history of the child and family (Table 1).
Thereafter, parents continue to receive a weekly question-
naire to ask whether their child has had symptoms in
the past week. If so, additional questions, regarding
the symptoms and consequences of the symptoms are
asked (Table 2). After one year and at the end of the
study (at two years) parents are asked to complete
the baseline questionnaire again to determine any
changes. Reminders will be sent for the baseline and
two follow-up questionnaires twice.
Reference data is collected through the ongoing
“child-is-ill” study, which collects weekly data in an
identical fashion in children that are considered to be
“normal as to being ill” by their parents. For this study
over 750 children, aged 2-18 years, are registered.
Statistics
Because this is an observational study, we did not
perform a power analysis. However, we estimate that
2,5% of parents of a child with DS participates in this
study. Given the potential sample size of approximately
4.500 children with DS aged <18 years in the Netherlands,
we estimate to include approximately 110 children. This
group size will allow us to study a larger cohort of
children with DS longitudinally. This cohort is a small
fraction of the total DS population, and the way parents
were selected is not random, having the consequence that
bias may show up. We will carefully address potential bias,
in particular by comparing all our outcomes with research
data available on children with DS. A second restriction is
that the size of the cohort may limit the possibilities of
subgroup analyses. A final restriction is the uncertainty
about the amount of missing data, as increasing numbers
of missing data reduce power. It is conceivable that
specific differences between children with DS and controls
cannot be detected.
Table 1 Annual questionnaire regarding background, daily activities and medical history of participating child with
Down syndrome
General questions
Child with Down syndrome Date of birth
Gender
Father/Mother Date of birth
History of allergy, asthma and/or eczema? Yes No
Siblings Number of older siblings
Number of younger siblings
History of allergy, asthma and/or eczema? Yes No
Does anyone smoke (almost) daily within the house? Yes No
Daily activities
Divide the 14 half-days present in each week between the following activities: Home Grandparents/family/host family
Child day care Special needs day care
Playgroup (age 2-4y) Pre-school kindergarten (age 4-5y)
Primary school (age 6-12y) Special primary school
Secondary school Special secondary school
Work placement Working
Other
If attending regular education, what grade is your child in?
Medical history
Compared to other children with the same age, the frequency of being ill is: Lower Equal Higher
Does your child have a history of any of the following illnesses, complaints or
medication usage?
Congenital heart disease Yes No
If yes, please specify VSD ASD AVSD Tetralogy of Fallot Other Unknown
If yes, was surgery performed? Yes No
Hypothyroid disease Yes No
If yes, diagnosed at what age?
Diabetes mellitus Yes No
If yes, diagnosed at what age?
Congenital malformations of the gastrointestinal tract Yes No
If yes, please specify: Oesophageal atresia Duodenal atresia Imperforate anus
Other Unknown
Celiac disease Yes No
If yes, diagnosed at what age?
Impaired hearing Yes No
If yes, diagnosed at what age?
Chronic snoring Yes No
If yes, present since what age?
Breathing with open mouth Yes No
If yes, present since what age?
Frequently suffering from serious colds Yes No, but did in the past No
If complaints used to be present, until what age?
Wheezing Yes No, but did in the past No
If complaints used to be present, until what age?
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Table 1 Annual questionnaire regarding background, daily activities and medical history of participating child with
Down syndrome (Continued)
Eye disorders Yes No
If yes, please specify: Cataract Glaucoma Strabismus Amblyopia
Wears glasses Other Unknown
Leukaemia Yes No
If yes, diagnosed at what age?
Antibiotic use for respiratory tract/ENT* infections in the past year 0-5 times 6-10 times more than 10 times
Hospital admission for RSV infection <2 years Yes No
ENT-surgery Yes No
If yes, please specify: Tympanic tubes Adenoidectomy Tonsillectomy
Daily antibiotic prophylaxis Yes No, but did in the past No
Inhaled corticoid for coughing, mucus and/or wheezing Yes No, but did in the past No
*ENT Ear-nose-throat.
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be presented in a descriptive manner using percentages.
Second, mixed model analysis will be performed at the end
of the study. This model allows analyzing data from re-
peated measurements as well as proper handling of missing
data. Also, effect of age as well as time (including seasonal
effects) can be taken into account. Early termination of
study participation by request of the parents or by >4 weeks
missing data prior to the endpoint will be marked as lost to
follow-up, and dealt with accordingly. Analysis will be
performed using IBM SPSS Statistics.
Handling and storage of data
Data will be handled and stored according to legal and
privacy guidelines. Parents will enter data concerning
their child in a central web-based database. Security is
guaranteed with login names, login codes and encryptedTable 2 Weekly questionnaire regarding medical symptoms i
Did your child have had any symptoms in the past week? No
If yes,*
Did you visit a doctor with your child? No
Yes, pae
Yes, oth
Did your child receive antibiotic treatment? No
Which symptoms were present? Earache
Stuffy no
Hoarse v
Was the temperature higher than 38.5°C (fever)? No
Did your child stay at home from school? No
Did your child stay at home from work placement? No
Did your child stay at home from work? No
Did you or your partner stay at home from work? No
*The additional questions are only shown after the first question is answered “yes”.
#ENT Ear-nose-throat.data transfer. The data of all subjects will be coded and
this coding will not be retraceable to the individual patient.
First, parents are not asked to enter the name of their child
or exact address. Second, the email address of the parents
will be blinded, stored encrypted and not accessible to the
researchers of this study. Access to the database will be
granted to the principal investigator and local investigator.
Data will be stored for 15 years.
Discussion
Although respiratory tract and ENT diseases are frequently
encountered in the care for children with DS, little is
known about their epidemiology. We have designed a
prospective web-based study, which allows us to describe
the incidence of respiratory symptoms, as well as their
relation to comorbidity, age and season. This information
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patients with DS on epidemiological data of respiratory
symptoms. Earlier studies were often based on retro-
spective chart reviews, which excludes complaints for
which no medical attention was sought by the parents
[5,7,15]. Also, there have been many studies based on a
single questionnaire where parents were asked if
complaints were present in the past year(s), which
leads to recall bias [9,11,16,21]. Other authors have
therefore used both chart review and retrospective
questionnaires to minimize the effect of recall bias [4,6].
Some studies are based on hospital admission/discharge
records or mortality records only, and all outpatient
symptoms are missed [8,12,13]. We expect our study to
give more insight in respiratory symptoms in children
with DS, which may help DS specialists to improve health
care for this group.
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